Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for Sarcoidosis Associated Pulmonary Hypertension
NCT01324999Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tadalafil in Sarcoidosis-associated pulmonary hypertension (SAPH), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: 6 Minute Walk Distance at Week 24. Started Mar 2011; status: completed.
02
Drugs
tadalafil
03
Conditions
Sarcoidosis-associated pulmonary hypertension (SAPH)
Beyond the preview
Go deeper on NCT01324999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01324999.